Arena Pharmaceuticals Inc ARNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
61.05UNCH (UNCH)
Volume
159,097
Close
61.05quote price arrow up+1.10 (+1.83%)
Volume
737,419
52 week range
45.50 - 90.19
Loading...
  • Open60.30
  • Day High61.24
  • Day Low59.40
  • Prev Close59.95
  • 52 Week High90.19
  • 52 Week High Date11/04/20
  • 52 Week Low45.50
  • 52 Week Low Date08/19/21

Key Stats

  • Market Cap3.728B
  • Shares Out61.07M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.48
  • YTD % Change-20.54

KEY STATS

  • Open60.30
  • Day High61.24
  • Day Low59.40
  • Prev Close59.95
  • 52 Week High90.19
  • 52 Week High Date11/04/20
  • 52 Week Low45.50
  • 52 Week Low Date08/19/21
  • Market Cap3.728B
  • Shares Out61.07M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.48
  • YTD % Change-20.54

RATIOS/PROFITABILITY

  • EPS (TTM)-8.17
  • P/E (TTM)-7.47
  • Fwd P/E (NTM)-6.45
  • EBITDA (MRQ)-506.603M
  • ROE (MRQ)-43.74%
  • Revenue (MRQ)60,000.00
  • Gross Margin (MRQ)35.70%
  • Net Margin (MRQ)-849,317.60%
  • Debt To Equity (MRQ)4.48%

EVENTS

  • Earnings Date11/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Arena Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the treatment of pain associated with Crohn's disease, and ralinepag (APD811) in Phase II evaluation for pulmonary arterial hypertension (PAH). The...
Garry Neil M.D.
Non-Executive Chairman
Amit Munshi
President
Laurie Stelzer CPA
Chief Financial Officer
Robert Lisicki
Executive Vice President
Joan Schmidt J.D.
Executive Vice President
Address
6154 Nancy Ridge Dr
San Diego, CA
92121-3223
United States

Top Peers

SYMBOLLASTCHG%CHG
IOVA
Iovance Biotherapeutics Inc
25.47+1.92+8.15%
KRTX
Karuna Therapeutics Inc
117.98+2.47+2.14%
IBRX
Immunitybio Inc
10.18+0.44+4.52%
RETA
Reata Pharmaceuticals Inc
109.94+2.37+2.20%
ALXO
ALX Oncology Holdings Inc
77.81-3.10-3.83%